Kivo reports that new drug access varies by state, with delays ranging from two to five months after FDA approval, impacting ...
On Monday morning, Novo Nordisk, the makers of the GLP-1 drug semaglutide (Ozempic and Wegovy), and Hims & Hers Health Inc. jointly announced a ceasefire to their growing hostilities via a new ...
Costco has partnered with Sesame and fertility network IVI RMA to offer members coordinated fertility care and discounted medications. The program ...
A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told ...
Over a dozen peptides may soon be unbanned. A doctor, med-spa physician, and healthcare executive explain what that means for ...
An Informational Analysis of TrimRx Compounded Semaglutide and Tirzepatide Programs, Telehealth Prescription Process, Published Pricing Disclosures, Pharmacy Partnerships and Patient Safety Informatio ...
Women and girls bear the brunt of collapsing healthcare and mass displacement Medical staff describe an exponential rise in maternal and neo-natal health ...
Durable 76% complete response (CR) rate at 12 months with 95% CR rate at any time in high-risk NMIBCBCG-unresponsive patients achieved an 80% CR rate at 12 months and 94% CR rate at any time ...
Dr. Hope Rugo explains how antibody-drug conjugates like Datroway and Trodelvy are shifting the treatment landscape for ...
The FDA has approved deucravacitinib for adults with active psoriatic arthritis, according to a press release from Bristol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results